The Dr Suzette Glasner Podcast
When Joe Rogan recently called Ibogaine a near-miraculous cure for opioid addiction — and the White House announced it would accelerate federal research into psychedelic medicines including Ibogaine — a powerful narrative took hold: one dose, addiction gone. The viral statistic? An 80% cure rate. But what does the research actually say? In this episode, addiction scientist and clinical psychologist Dr. Suzette Glasner traces that 80% number back to its potential sources in the published research literature — and walks through what the studies to date have actually shown. Dr. Glasner explains the data through the lens of conservative methodology for interpreting treatment success rates, which suggests that the outcomes are closer to 50% abstinent at one month and 30% at one year. That’s still a meaningful signal worth investing in. It’s just not a miracle cure. Watch the full episode here: Dr. Glasner also unpacks what Ibogaine is and why it’s drawn the attention of addiction researchers — particularly its action in the brain’s reward circuit. She gets into the cardiac risks and how they can be reduced before and during treatment (e.g., cardiac screening, EKG monitoring during the session, and co-administered magnesium). 🧠 Key Takeaways The bottom line: the scientific signal is real, and accelerated federal investment in rigorous trials is genuinely needed. But the gap between what the evidence shows and what people are hearing in viral podcast clips is where people can get hurt. And while we wait for clinical trials to be completed, FDA-approved medications for opioid use disorder already exist, save lives, and are available right now. 🔍 Episode Breakdown 00:00 [https://www.youtube.com/watch?v=X9UR79FN3Vo] Joe Rogan and the ibogaine "miracle" story00:47 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=47s] The "80% cured, 90%+ on the second dose" claim01:22 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=82s] Trump's executive order accelerating psychedelic research01:59 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=119s] Why this addiction scientist is excited — and concerned04:14 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=254s] Three questions this episode answers04:35 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=275s] What ibogaine is06:18 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=378s] How ibogaine works in the brain: GDNF and the reward circuit08:18 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=498s] What the clinical evidence actually shows10:26 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=626s] Breaking down the 80% figure13:50 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=830s] The 2024 Stanford TBI study and the gap in the evidence15:40 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=940s] The safety conversation that isn't happening: hERG and QT17:56 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=1076s] Documented deaths and why cardiac monitoring matters19:11 [https://www.youtube.com/watch?v=X9UR79FN3Vo&t=1151s] Dr. Glasner’s final take and practical guidance Listen to Episode 51 for an evidence-based look at what Ibogaine can — and can’t — do, and why the gap between the science and the headlines matters. 📩 Questions or topic suggestions? Email AskDrGlasner@gmail.com [AskDrGlasner@gmail.com] 🔗 Subscribe for evidence-based discussions on addiction, recovery, and mental health : www.YouTube.com/@drglasner This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit drglasner.substack.com [https://drglasner.substack.com?utm_medium=podcast&utm_campaign=CTA_1]
57 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Dr Suzette Glasner Podcast!